What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Antibiotics
Immunology, Mucormycosis, Microbiology, Antibiotic resistance and Intensive care medicine are his primary areas of study.
The Immunology study combines topics in areas such as Bacteremia and Staphylococcus aureus.
His Mucormycosis research is multidisciplinary, incorporating perspectives in Amphotericin B, Caspofungin, Pharmacotherapy and Combination therapy, Pharmacology.
The various areas that Brad Spellberg examines in his Microbiology study include Avibactam and In vivo.
His Antibiotic resistance course of study focuses on Drug resistance and Biotechnology.
His studies in Intensive care medicine integrate themes in fields like Voriconazole and Posaconazole.
His most cited work include:
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America (3371 citations)
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America (3371 citations)
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America (1173 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Microbiology, Mucormycosis, Intensive care medicine and Antibiotics.
His work investigates the relationship between Immunology and topics such as Bacteremia that intersect with problems in Sepsis and Internal medicine.
His Microbiology research incorporates themes from Staphylococcus aureus, Fungal protein, Virulence and Virology.
His Mucormycosis study combines topics in areas such as Zygomycosis, Amphotericin B, Combination therapy and Mycosis.
Brad Spellberg has researched Intensive care medicine in several fields, including Clinical trial and MEDLINE.
His Antibiotics study focuses on Antibiotic resistance in particular.
He most often published in these fields:
- Immunology (37.74%)
- Microbiology (34.84%)
- Mucormycosis (19.03%)
What were the highlights of his more recent work (between 2016-2021)?
- Antibiotics (19.68%)
- Intensive care medicine (16.13%)
- Microbiology (34.84%)
In recent papers he was focusing on the following fields of study:
Brad Spellberg mainly focuses on Antibiotics, Intensive care medicine, Microbiology, Antibiotic resistance and Internal medicine.
Brad Spellberg studies Colistin which is a part of Microbiology.
His Antibiotic resistance research incorporates elements of Klebsiella pneumoniae and Antimicrobial.
In his research on the topic of Internal medicine, Immunology, Staphylococcus aureus, Antibacterial resistance and Relative risk is strongly related with Bacteremia.
His research in Immunology intersects with topics in Aspiration pneumonia and Ventilator-associated pneumonia.
The concepts of his MEDLINE study are interwoven with issues in Specialty, Public health and Library science.
Between 2016 and 2021, his most popular works were:
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
- Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? (115 citations)
- Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering. (48 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Antibiotics
Antibiotics, Intensive care medicine, Microbiology, Antibiotic resistance and Internal medicine are his primary areas of study.
His Antibiotics study combines topics from a wide range of disciplines, such as Concomitant, Osteomyelitis, Bone remodeling and Debridement.
His Intensive care medicine research includes themes of Antibiotic Stewardship and MEDLINE.
Brad Spellberg combines subjects such as Ceftazidime/avibactam and Avibactam with his study of Microbiology.
His Antibiotic resistance research is multidisciplinary, relying on both Cohort study and Pneumonia.
Brad Spellberg has included themes like Bacteremia and Virus in his Internal medicine study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
